Skip to Main Content

Author Details

Mara Rosenberg
Broad Institute of MIT and Harvard
2013
44
29
PMIDPaper TitleJournal TitlePublished Year
35084050Implementation of a prostate cancer-specific targeted sequencing panel for credentialing of patient-derived cell lines and genomic characterization of patient samples.Prostate2022
36307214Comprehensive molecular characterization of a rare case of Philadelphia chromosome-positive acute myeloid leukemia.Cold Spring Harb Mol Case Stud2022
35084050Implementation of a prostate cancer-specific targeted sequencing panel for credentialing of patient-derived cell lines and genomic characterization of patient samples.Prostate2022
36307214Comprehensive molecular characterization of a rare case of Philadelphia chromosome-positive acute myeloid leukemia.Cold Spring Harb Mol Case Stud2022
32302173Constraints on Lorentz Invariance Violation from HAWC Observations of Gamma Rays above 100 TeV.Phys Rev Lett2020
32004015Multiple Galactic Sources with Emission Above 56 TeV Detected by HAWC.Phys Rev Lett2020
32302173Constraints on Lorentz Invariance Violation from HAWC Observations of Gamma Rays above 100 TeV.Phys Rev Lett2020
32754299Genomic markers of midostaurin drug sensitivity in FLT3 mutated and FLT3 wild-type acute myeloid leukemia patients.Oncotarget2020
33028839Framework for quality assessment of whole genome cancer sequences.Nat Commun2020
32004015Multiple Galactic Sources with Emission Above 56 TeV Detected by HAWC.Phys Rev Lett2020
33028839Framework for quality assessment of whole genome cancer sequences.Nat Commun2020
32754299Genomic markers of midostaurin drug sensitivity in FLT3 mutated and FLT3 wild-type acute myeloid leukemia patients.Oncotarget2020
30425048CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells.Blood2019
30425048CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells.Blood2019
31164371Genomic Evolutionary Patterns of Leiomyosarcoma and Liposarcoma.Clin Cancer Res2019
31048320The TP53 Apoptotic Network Is a Primary Mediator of Resistance to BCL2 Inhibition in AML Cells.Cancer Discov2019
31145495The combination of NPM1, DNMT3A, and IDH1/2 mutations leads to inferior overall survival in AML.Am J Hematol2019
31145495The combination of NPM1, DNMT3A, and IDH1/2 mutations leads to inferior overall survival in AML.Am J Hematol2019
31164371Genomic Evolutionary Patterns of Leiomyosarcoma and Liposarcoma.Clin Cancer Res2019
31048320The TP53 Apoptotic Network Is a Primary Mediator of Resistance to BCL2 Inhibition in AML Cells.Cancer Discov2019
29713087Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.Nat Med2018
30482938Publisher Correction: Very-high-energy particle acceleration powered by the jets of the microquasar SS 433.Nature2018
29955181Publisher Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.Nat Med2018
29955182Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.Nat Med2018
30283106Very-high-energy particle acceleration powered by the jets of the microquasar SS 433.Nature2018
29941871DeTiN: overcoming tumor-in-normal contamination.Nat Methods2018
29713087Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.Nat Med2018
29941871DeTiN: overcoming tumor-in-normal contamination.Nat Methods2018
29955181Publisher Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.Nat Med2018
29955182Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.Nat Med2018
30482938Publisher Correction: Very-high-energy particle acceleration powered by the jets of the microquasar SS 433.Nature2018
30283106Very-high-energy particle acceleration powered by the jets of the microquasar SS 433.Nature2018
28522256Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers.Gastroenterology2017
28658208Recurrent and functional regulatory mutations in breast cancer.Nature2017
28522256Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers.Gastroenterology2017
29109393Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors.Nat Commun2017
29146808Extended gamma-ray sources around pulsars constrain the origin of the positron flux at Earth.Science2017
29109393Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors.Nat Commun2017
29146808Extended gamma-ray sources around pulsars constrain the origin of the positron flux at Earth.Science2017
28658208Recurrent and functional regulatory mutations in breast cancer.Nature2017
26711114Corrigendum: The genomic landscape of juvenile myelomonocytic leukemia.Nat Genet2016
27348297The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis.Nat Genet2016
27149842Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma.Cell Rep2016
27167109A comparative assessment of clinical whole exome and transcriptome profiling across sequencing centers: implications for precision cancer medicine.Oncotarget2016
27158780Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas.Nat Genet2016
26711114Corrigendum: The genomic landscape of juvenile myelomonocytic leukemia.Nat Genet2016
27760322Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma.Cell Rep2016
27760322Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma.Cell Rep2016
27149842Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma.Cell Rep2016
27167109A comparative assessment of clinical whole exome and transcriptome profiling across sequencing centers: implications for precision cancer medicine.Oncotarget2016
  • 1 - 50 of 88

Recommended Authors

Sebastian Uhrig
National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Career Start Year 2016
Number of shared co-authors 9
Zachary L Skidmore
Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 7
Aparna Pallavajjala
Johns Hopkins University School of Medicine
Career Start Year 2014
Number of shared co-authors 1
Richard de Borja
The Hospital for Sick Children
Career Start Year 2012
Number of shared co-authors 5
Jiguang Wang
The Hong Kong University of Science and Technology
Career Start Year 2012
Number of shared co-authors 18
Arshi Arora
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 6
Natalie J??ger
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2010
Number of shared co-authors 26
Francesco Favero
Universita del Piemonte Orientale
Career Start Year 2010
Number of shared co-authors 3
Gunes Gundem
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 11
Christopher A Miller
Washington University School of Medicine
Career Start Year 2009
Number of shared co-authors 31
Francine B de Abreu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
Kilannin Krysiak
Washington University School of Medicine
Career Start Year 2007
Number of shared co-authors 6
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Career Start Year 2006
Number of shared co-authors 12
Linghua Wang
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 31
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 12
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 2
Michael Rusch
St Jude Children's Research Hospital
Career Start Year 2003
Number of shared co-authors 8
Malachi Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 24
Sherri Z Millis
Foundation Medicine Inc
Career Start Year 2003
Number of shared co-authors 0
Michael D McLellan
McDonnell Genome Institute, Washington University in St. Louis
Career Start Year 2003
Number of shared co-authors 46
Peter Van Loo
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 14
Debyani Chakravarty
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 47
Volker Endris
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2001
Number of shared co-authors 5
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 74
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year 1996
Number of shared co-authors 20
Siraj M Ali
Foundation Medicine
Career Start Year 1995
Number of shared co-authors 13
Jinghui Zhang
Changhai Hospital, Second Military Medical University
Career Start Year 1992
Number of shared co-authors 29
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 42
Mark J Routbort
University of Texas MD Anderson Cancer Center
Career Start Year 1989
Number of shared co-authors 13
Marc Ladanyi
Memorial Sloan Kettering Cancer Center
Career Start Year 1984
Number of shared co-authors 50

Collaborators

Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 28
Chip Stewart
Broad Institute of MIT and Harvard
Co-authored papers 17
Amaro Taylor-Weiner
Co-authored papers 16
Michael S Lawrence
Co-authored papers 16
Matthew Meyerson
Broad Institute
Co-authored papers 14
Scott L Carter
Co-authored papers 13
Eliezer M Van Allen
Dana-Farber Cancer Institute
Co-authored papers 12
Levi A Garraway
Broad Institute of Harvard and MIT
Co-authored papers 11
Stacey Gabriel
Broad Institute of MIT and Harvard
Co-authored papers 10
Todd R Golub
Broad Institute of MIT and Harvard
Co-authored papers 10
Kristian Cibulskis
Co-authored papers 10
Aaron McKenna
Co-authored papers 9
Jaegil Kim
Co-authored papers 8
Eric S Lander
Vanderbilt-Ingram Cancer Center, Vanderbilt University
Co-authored papers 7
Rameen Beroukhim
Co-authored papers 7
Esther Rheinbay
Co-authored papers 7
Chandra Sekhar Pedamallu
Broad Institute
Co-authored papers 6
Aaron R Thorner
Co-authored papers 6
Julian M Hess
Broad Institute of MIT and Harvard
Co-authored papers 5
Gordon Saksena
Broad Institute of Massachusetts Institute of Technology and Harvard
Co-authored papers 5
Carrie Sougnez
The Broad Institute of Harvard and MIT
Co-authored papers 5
Nikhil Wagle
Dana-Farber Cancer Institute
Co-authored papers 5
Daniel Auclair
Co-authored papers 5
Martina Schneider
University of Maryland, College Park
Co-authored papers 5
Dimitri Livitz
Co-authored papers 5
Donna Neuberg
Co-authored papers 5
Sara Seepo
Co-authored papers 5
Jeremiah Wala
The Broad Institute of MIT and Harvard
Co-authored papers 5
Adam Tracy
Co-authored papers 5
Catherine J Wu
Co-authored papers 5
Release 1.2